awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36194219-941EA30D-B73E-418C-9D11-6F2FE879AE0D
Q36194219-941EA30D-B73E-418C-9D11-6F2FE879AE0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36194219-941EA30D-B73E-418C-9D11-6F2FE879AE0D
S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic Gastric Cancer: A Randomized, Open-Label Phase 2 Trial
P2860
Q36194219-941EA30D-B73E-418C-9D11-6F2FE879AE0D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36194219-941EA30D-B73E-418C-9D11-6F2FE879AE0D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
02b1a59fa0b6385d9afb002c3d46b209ec2abc71
P2860
Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).